Exhibit
10.1


 


 


Securities
Purchase Agreement


 


This
Securities Purchase Agreement (this “Agreement”),
dated as of November __, 2022, is entered into by and between HUMBL, Inc., a Delaware
corporation, its successors and/or assigns (“Company”), and [______], a
[______] limited liability company, its successors and/or assigns (“Investor”).


 


A.
Company and Investor are executing and delivering this Agreement in reliance upon an exemption from securities registration afforded
by the Securities Act of 1933, as amended (the “Securities Act”), and the rules and regulations promulgated thereunder
by the United States Securities and Exchange Commission (the “SEC”).


 


B.
Investor desires to purchase and Company desires to issue and sell, upon the terms and conditions set forth in this Agreement (i) [_______]
shares (the “Shares”) of common stock, $0.00001 par value per share, of Company (the “Common Stock”),
and (ii) a Warrant to Purchase Shares of Common Stock, substantially in the form attached hereto as Exhibit A (the “Warrant”).


 


C.
This Agreement, the Warrant, and all other certificates, documents, agreements, resolutions and instruments delivered to any party under
or in connection with this Agreement, as the same may be amended from time to time, are collectively referred to herein as the “Transaction
Documents”.


 


D.
For purposes of this Agreement: “Warrant Shares” means all shares of Common Stock issuable upon the exercise of or
pursuant to the Warrant; and “Securities” means the Shares, the Warrant, and the Warrant Shares.


 


NOW,
THEREFORE, in consideration of the above recitals and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, Company and Investor hereby agree as follows:


 


1.
Purchase and Sale of Securities


 


1.1.
Purchase of Securities. Company shall issue and sell to Investor and Investor shall purchase from Company the Shares and the Warrant.
In consideration thereof, Investor shall pay $[_______] (the “Purchase Price”) to Company via wire transfer of immediately
available funds.


 


1.2.
Form of Payment. On the Closing Date (as defined below), Investor shall pay the Purchase Price to Company via wire transfer of
immediately available funds against delivery of the Shares.


 


1.3.
Closing Date. Subject to the satisfaction (or written waiver) of the conditions set forth in Section 3 and Section 4 below, the
date of the issuance and sale of the Securities pursuant to this Agreement (the “Closing Date”) shall be November
__, 2022, or such other mutually agreed upon date. The closing of the transactions contemplated by this Agreement (the “Closing”)
shall occur on the Closing Date by means of the exchange by email of signed .pdf documents.


 


2.
Investor’s Representations and Warranties.


 


2.1.
Existence and Power. Investor is a limited liability company duly organized, validly existing and in good standing under the laws
of the state of its formation and has the requisite corporate power to own its properties and to carry on its business as now being conducted.


 


2.2.
Authorization; No Contravention. The execution, delivery and performance by Investor of this Agreement and the transactions contemplated
hereby (a) have been duly authorized by all necessary officers, partners, managers or members of Investor, (b) do not contravene the
terms of Investor’s organizational documents, or any amendment thereof, (c) do not materially violate, conflict with or result
in any material breach or contravention of, or the creation of any lien under, any contractual obligation of Investor or any requirement
of law applicable to Investor, and (d) do not materially violate any orders of any governmental authority against, or binding upon, Investor
to the knowledge of Investor.


 



    1


     


     


2.3.
Binding Effect. This Agreement has been duly executed and delivered by Investor and constitutes the legal, valid and binding obligations
of Investor, enforceable against Investor in accordance with its terms, except as enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, fraudulent conveyance or transfer, moratorium or similar laws affecting the enforcement of creditors’
rights generally or by equitable principles relating to enforceability (regardless of whether considered in a proceeding at law or in
equity).


 


2.4.
Restricted Securities. Investor understands that the Securities will not be registered under the Securities Act at the time of
purchase and, therefore, cannot be resold unless registered under the Securities Act and applicable state securities laws or unless an
exemption from such registration requirements is available.


 


2.5.
Accredited Investor. Investor is an “Accredited Investor” within the meaning of Rule 501 of Regulation D under the
Securities Act, as presently in effect.


 


2.6.
Disclosure of Information. Investor has been furnished with, and has had access to, such information as it considers necessary
or appropriate for deciding whether to enter into this Agreement, and Investor has had an opportunity to ask questions and receive answers
from Company and its officers concerning Company’s financial situation, business, prospects, and any other matter that Investor
has deemed relevant or important in determining whether to enter into this Agreement. Among other things, Investor is aware that Company’s
business prospects are speculative. Investor has had the opportunity to consult with counsel of its choosing with respect to this Agreement
and the transactions contemplated herein. No representations or warranties have been made to Investor by Company, or any of its respective
officers, directors, employees, agents, sub-agents, affiliates or subsidiaries, other than the representations of Company contained herein,
and in purchasing the Securities hereunder, Investor is not relying upon any representations of Company other than those contained herein.


 


2.7.
Investment Risk. Investor is aware that its purchase of the Securities pursuant to this Agreement is a speculative investment
that is subject to the risk of complete loss. Investor is able, without impairing Investor’s financial condition, to suffer a complete
loss of such investment in Company.


 


2.8.
Sophisticated Investor. Investor has such knowledge and experience in financial and business matters that Investor is capable
of evaluating the merits and risks of such investment, is able to incur a complete loss of such investment and is able to bear the economic
risk of such investment for an indefinite period of time. Investor has not been formed solely for the purpose of making this investment
and is purchasing the Securities for its own account for investment, not as a nominee or agent, and not with a view to, or for resale
in connection with, the distribution thereof.


 


3.
Company’s Representations; Warranties and Covenants.


 


3.1.
Legal Capacity; Existence and Power. Company is a corporation, duly organized, validly existing and in good standing under the
laws of the jurisdiction of its formation, with the requisite power and authority to enter into this Agreement and perform its obligations
hereunder and each other document contemplated hereby to which Company is or will be a party, and to consummate the transactions contemplated
hereby and thereby.


 


3.2.
Authorization; No Contravention. The execution, delivery and performance by Company of this Agreement and the transactions contemplated
hereby (a) have been duly authorized by all necessary officers, managers or members of Company, (b) do not contravene the terms of Company’s
charter documents, or any amendment thereof, and (c) do not materially violate, conflict with or result in any material breach or contravention
of, or the creation of any lien under, any contractual obligation of Company.


 


3.3.
Governmental Authorization; Third Party Consents. To the best of Company’s knowledge, no approval, consent, compliance,
exemption, authorization or other action by, or notice to, or filing with, any governmental authority or any other person, and no lapse
of a waiting period under any requirement of law, is necessary or required in connection with the execution, delivery or performance
by, or enforcement against, Company, of this Agreement.


 


3.4.
Binding Effect. This Agreement has been duly executed and delivered by Company and constitutes the legal, valid and binding obligations
of Company, enforceable against Company in accordance with its terms, except as enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, fraudulent conveyance or transfer, moratorium or similar laws affecting the enforcement of creditors’
rights generally or by equitable principles relating to enforceability (regardless of whether considered in a proceeding at law or in
equity).


 



    2


     


     


3.5.
Reporting. Company has filed all reports, schedules, forms, statements and other documents required to be filed under the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), for the last 12 months (or such shorter period Company was
required by law or regulation to file such material) (the “SEC Reports”) on a timely basis or has received a valid
extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective
dates, the SEC Reports complied in all material respects with the requirements of the Exchange Act, and none of the SEC Reports, when
filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The financial
statements of Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules
and regulations of the Exchange Act with respect thereto as in effect at the time of filing. Such financial statements have been prepared
in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of Company as of and
for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements,
to normal, immaterial, year-end audit adjustments.


 


3.6.
No Material Adverse Effect. No change or event has occurred since the filing of Company’s last SEC Report that could reasonably
be expected to result in a material adverse effect to Company’s business. Except as disclosed in the SEC Reports, there is no action,
suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of Company, threatened against or affecting
Company, any subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency
or regulatory authority (federal, state, county, local or foreign) (collectively, an “Action”) that could reasonably
be expected to have a material adverse effect on Company. Except as disclosed in the SEC Reports, neither Company nor any subsidiary,
nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal
or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of Company, there is not pending
or contemplated, any investigation by the SEC involving Company or any current or former director or officer of Company. OTC Markets
has not issued any stop order or other order suspending trading of Company’s Common Stock.


 


4.
Registration Statement. Company agrees to register the Shares in a registration statement and to file such registration statement
within 120 days of the Closing Date.


 


5.
Conditions to Company’s Obligation to Sell. The obligation of Company hereunder to issue and sell the Securities to Investor
at the Closing is subject to the satisfaction, on or before the Closing Date, of each of the following conditions:


 


5.1.
Investor shall have executed this Agreement and delivered the same to Company.


 


5.2.
Investor shall have delivered the Purchase Price to Company.


 


6.
Conditions to Investor’s Obligation to Purchase. The obligation of Investor hereunder to purchase the Securities at the
Closing is subject to the satisfaction, on or before the Closing Date, of each of the following conditions, provided that these conditions
are for Investor’s sole benefit and may be waived by Investor at any time in its sole discretion:


 


6.1.
Company shall have executed this Agreement and delivered the same to Company.


 


6.2.
Company shall have delivered to Investor fully executed copies of all other Transaction Documents required to be executed by Company
herein or therein.


 



    3


     


     


7.
Miscellaneous. The provisions set forth in this Section 7 shall apply to this Agreement, as well as all other Transaction Documents
as if these terms were fully set forth therein; provided, however, that in the event there is a conflict between any provision set forth
in this Section 7 and any provision in any other Transaction Document, the provision in such other Transaction Document shall govern.


 


7.1.
Governing Law; Venue. This Agreement shall be construed and enforced in accordance with, and all questions concerning the construction,
validity, interpretation and performance of this Agreement shall be governed by, the internal laws of the State of California, without
giving effect to any choice of law or conflict of law provision or rule (whether of the State of California or any other jurisdiction)
that would cause the application of the laws of any jurisdiction other than the State of California. Each party hereto hereby (i) consents
to and expressly submits to the exclusive personal jurisdiction of any state or federal court sitting in San Diego County, California,
(ii) expressly submits to the exclusive venue of any such court for the purposes hereof, and (iii) waives any claim of improper venue
and any claim or objection that such courts are an inconvenient forum or any other claim, defense or objection to the bringing of any
such proceeding in such jurisdiction or to any claim that such venue of the suit, action or proceeding is improper.


 


7.2.
Counterparts. Each Transaction Document may be executed in any number of counterparts, each of which shall be deemed an original,
but all of which together shall constitute one instrument. The parties acknowledge and agree that this Agreement and all other Transaction
Documents may be executed by electronic signature, which shall be considered as an original signature for all purposes and shall have
the same force and effect as an original signature. The parties hereto confirm that any electronic copy of another party’s executed
counterpart of a Transaction Document (or such party’s signature page thereof) will be deemed to be an executed original thereof.


 


7.3.
Headings. The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the interpretation
of, this Agreement.


 


7.4.
Severability. In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule
of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to
conform to such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect
the validity or enforceability of any other provision hereof.


 


7.5.
Entire Agreement. This Agreement, together with the other Transaction Documents, contains the entire understanding of the parties
with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither Company nor Investor
makes any representation, warranty, covenant or undertaking with respect to such matters. For the avoidance of doubt, all prior term
sheets or other documents between Company and Investor, or any affiliate thereof, related to the transactions contemplated by the Transaction
Documents (collectively, “Prior Agreements”), that may have been entered into between Company and Investor, or any
affiliate thereof, are hereby null and void and deemed to be replaced in their entirety by the Transaction Documents. To the extent there
is a conflict between any term set forth in any Prior Agreement and the term(s) of the Transaction Documents, the Transaction Documents
shall govern.


 


7.6.
Amendments. No provision of this Agreement may be waived or amended other than by an instrument in writing signed by both parties
hereto.


 


7.7.
Notices. Any notice required or permitted hereunder shall be given in writing (unless otherwise specified herein) and shall be
deemed effectively given on the earliest of: (i) the date delivered, if delivered by personal delivery as against written receipt therefor
or by email to an executive officer, or by facsimile (with successful transmission confirmation), (ii) the earlier of the date delivered
or the third business day after deposit, postage prepaid, in the United States Postal Service by certified mail, or (iii) the earlier
of the date delivered or the third business day after mailing by express courier, with delivery costs and fees prepaid, in each case,
addressed to each of the other parties thereunto entitled at the addresses previously provided to the other party (or at such other addresses
as such party may designate by five (5) calendar days’ advance written notice similarly given to each of the other parties hereto).


 



    4


     


     


7.8.
Successors and Assigns. This Agreement or any of the severable rights and obligations inuring to the benefit of or to be performed
by Investor hereunder may be assigned by Investor to its affiliates, in whole or in part, without the need to obtain Company’s
consent thereto. Except as set forth above, neither Investor nor Company may assign its rights or obligations under this Agreement or
delegate its duties hereunder without the prior written consent of the other party.


 


7.9.
Survival. The representations and warranties of the parties and the agreements and covenants set forth in this Agreement shall
survive the Closing hereunder notwithstanding any due diligence investigation conducted by or on behalf of each party. Each party agrees
to indemnify and hold harmless the other and all its respective officers, directors, employees, attorneys, and agents for loss or damage
arising as a result of or related to any breach or alleged breach by the other party of any of its representations, warranties and covenants
set forth in this Agreement or any of its covenants and obligations under this Agreement, including advancement of expenses as they are
incurred.


 


7.10.
Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and
shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.


 


7.11.
Attorneys’ Fees. In the event any action is filed by either party against the other to interpret or enforce any of the Transaction
Documents, the unsuccessful party to such action agrees to pay to the prevailing party all costs and expenses, including reasonable attorneys’
fees incurred therein, including the same with respect to an appeal. The “prevailing party” shall be the party in whose favor
a judgment is entered, regardless of whether judgment is entered on all claims asserted by such party and regardless of the amount of
the judgment; or where, due to the assertion of counterclaims, judgments are entered in favor of and against both parties, then the judge
shall determine the “prevailing party” by taking into account the relative dollar amounts of the judgments or, if the judgments
involve nonmonetary relief, the relative importance and value of such relief.


 


7.12.
Waiver. No waiver of any provision of this Agreement shall be effective unless it is in the form of a writing signed by the party
granting the waiver. No waiver of any provision or consent to any prohibited action shall constitute a waiver of any other provision
or consent to any other prohibited action, whether or not similar. No waiver or consent shall constitute a continuing waiver or consent
or commit a party to provide a waiver or consent in the future except to the extent specifically set forth in writing.


 


7.13.
Waiver of Jury Trial. EACH PARTY TO THIS AGREEMENT IRREVOCABLY WAIVES ANY AND ALL RIGHTS SUCH PARTY MAY HAVE TO DEMAND THAT ANY
ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR IN ANY WAY RELATED TO THIS AGREEMENT, ANY OTHER TRANSACTION DOCUMENT, OR THE RELATIONSHIPS
OF THE PARTIES HERETO BE TRIED BY JURY. THIS WAIVER EXTENDS TO ANY AND ALL RIGHTS TO DEMAND A TRIAL BY JURY ARISING UNDER COMMON LAW
OR ANY APPLICABLE STATUTE, LAW, RULE OR REGULATION. FURTHER, EACH PARTY HERETO ACKNOWLEDGES THAT SUCH PARTY IS KNOWINGLY AND VOLUNTARILY
WAIVING SUCH PARTY’S RIGHT TO DEMAND TRIAL BY JURY.


 


7.14.
Time is of the Essence. Time is expressly made of the essence with respect to each and every provision of this Agreement and the
other Transaction Documents.


 


7.15.
Voluntary Agreement. Investor has carefully read this Agreement and each of the other Transaction Documents and has asked any
questions needed for Investor to understand the terms, consequences and binding effect of this Agreement and the Securities and fully
understand them. Investor has had the opportunity to seek the advice of an attorney of Investor’s choosing, or has waived the right
to do so, and is executing this Agreement and the Securities voluntarily and without any duress or undue influence by Company or anyone
else.


 


[Remainder
of page intentionally left blank; signature page follows]


 



    5


     


     


IN
WITNESS WHEREOF, the undersigned Investor and Company have caused this Agreement to be duly executed as of the date first above written.


 


	 	INVESTOR:
	 	 
	 	[______]


 


	 	By:	 
	 	 	[______]


 


	 	COMPANY:
	 	 	 
	 	HUMBL,
    Inc.
	 	 	 
	 	By:	 
	 	 	Brian
    Foote, CEO


 


[Signature
Page to Securities Purchase Agreement]


 



     


     


     


EXHIBIT
A


 


Warrant


 


NEITHER
THIS WARRANT NOR THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933,
AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD, PLEDGED, ASSIGNED, OR OTHERWISE
TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES
LAWS OR (2) THE COMPANY RECEIVES AN OPINION OF COUNSEL TO THE HOLDER OF THIS WARRANT OR SUCH SECURITIES, WHICH COUNSEL AND OPINION ARE
REASONABLY SATISFACTORY TO THE COMPANY, THAT THIS WARRANT OR SUCH SECURITIES, AS APPLICABLE, MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED,
OR OTHERWISE TRANSFERRED IN THE MANNER CONTEMPLATED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR APPLICABLE
STATE SECURITIES LAWS.


 


HUMBL,
INC.


 


WARRANT
TO PURCHASE SHARES OF COMMON STOCK


 


8.
Issuance. For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by HUMBL,
Inc., a Delaware corporation, its successors and assigns (“Company”), [_______], a [_______] limited liability
company, its successors and/or registered assigns (“Investor”), is hereby granted the right to purchase at any time
on or after the Issue Date (as defined below) until [THREE YEARS FROM THE ISSUE DATE] (the “Expiration Date”), [_______]
fully paid and non-assessable shares (the “Warrant Shares”) of Company’s common stock, par value $0.00001 per
share (the “Common Stock”), as such number may be adjusted from time to time pursuant to the terms and conditions
of this Warrant to Purchase Shares of Common Stock (this “Warrant”).


 


This
Warrant is being issued pursuant to the terms of that certain Securities Purchase Agreement dated [_______], to which Company and Investor
are parties (as the same may be amended from time to time, the “Purchase Agreement”). Certain capitalized terms used
herein are defined in Attachment 1 attached hereto and incorporated herein by this reference. This Warrant was issued to Investor
on [_______] (the “Issue Date”).


 


9.
Exercise of Warrant.


 


9.1.
General.


 


(a)
This Warrant is exercisable in whole or in part at any time and from time to time commencing on the Issue Date and ending on the Expiration
Date. Such exercise shall be effectuated by submitting to Company (either by delivery to Company or by email or facsimile transmission)
a completed and signed Notice of Exercise substantially in the form attached to this Warrant as Exhibit A (the “Notice
of Exercise”). The date a Notice of Exercise is delivered to Company shall be the “Exercise Date,” provided
that, if such exercise represents the full exercise of the outstanding balance of this Warrant, Investor shall tender this Warrant to
Company within five (5) Trading Days thereafter, but only if the Warrant Shares to be delivered pursuant to the Notice of Exercise have
been delivered to Investor as of such date. The Notice of Exercise shall be executed by Investor and shall indicate the number of Warrant
Shares to be issued pursuant to such exercise


 



     


     


     


(b)
Notwithstanding any other provision contained herein or in any other Transaction Document to the contrary, at any time prior to the Expiration
Date, Investor may elect a “cashless” exercise of this Warrant for any Warrant Shares, in which event the Company shall issue
to Investor a number of Warrant Shares computed using the following formula:


 


X
= Y (A-B)


        A



 


	Where:	X
    =	the
    number of Warrant Shares to be issued to Investor.
	 	 	 
	 	Y
    = 	the
    number of Warrant Shares that the Investor elects to purchase under this Warrant (at the date of such calculation).
	 	 	 
	 	A
    =	the
    Closing Trade Price (on the date two Trading Days prior to the Exercise Date).
	 	 	 
	 	B
    =	Exercise
    Price.


 


(c)
If the Notice of Exercise form elects a “cash” exercise, the Exercise Price per share of Common Stock for the Warrant Shares
shall be payable, at the election of Investor, in cash or by certified or official bank check or by wire transfer in accordance with
instructions provided by Company at the request of Investor.


 


(d)
Upon the appropriate payment to Company of the Exercise Price for the Warrant Shares, Company shall promptly, but in no case later than
the date that is ten (10) Trading Days following the date the Exercise Price is paid to Company (the “Delivery Date”),
deliver or cause Company’s Transfer Agent to deliver the applicable Warrant Shares electronically via the DWAC system to the account
designated by Investor on the Notice of Exercise. If for any reason Company is not able to so deliver the Warrant Shares via the DWAC
system, Company shall instead, on or before the applicable date set forth above in this subsection, issue and deliver to Investor or
its broker (as designated in the Notice of Exercise), via reputable overnight courier, a certificate, registered in the name of Investor
or its designee, representing the applicable number of Warrant Shares.


 


9.2.
Ownership Limitation. Notwithstanding anything to the contrary contained in this Warrant, if at any time Lender shall or would
be issued shares of Common Stock under this Warrant, but such issuance would cause Lender (together with its affiliates) to beneficially
own a number of shares exceeding 4.99% of the number of shares of Common Stock outstanding on such date (including for such purpose the
shares of Common Stock issuable upon such issuance) (the “Maximum Percentage”), then Borrower shall not issue to Lender
shares of Common Stock which would exceed the Maximum Percentage. The ownership limitation is enforceable, unconditional and non-waivable
and shall apply to all affiliates and assigns of Lender.


 


10.
Mutilation or Loss of Warrant. Upon receipt by Company of evidence satisfactory to it of the loss, theft, destruction or mutilation
of this Warrant, and (in the case of loss, theft or destruction) receipt of reasonably satisfactory indemnification, and (in the case
of mutilation) upon surrender and cancellation of this Warrant, Company will execute and deliver to Investor a new Warrant of like tenor
and date and any such lost, stolen, destroyed or mutilated Warrant shall thereupon become void.


 


11.
Rights of Investor. Investor shall not, by virtue of this Warrant alone, be entitled to any rights of a stockholder in Company,
either at law or in equity, and the rights of Investor with respect to or arising under this Warrant are limited to those expressed in
this Warrant and are not enforceable against Company except to the extent set forth herein


 


12.
Adjustments. If Company shall issue any shares of Common Stock as a stock dividend or subdivide the number of outstanding shares
of Common Stock into a greater number of shares, then, in either such case, the Exercise Price in effect before such dividend or subdivision
shall be proportionately reduced and the number of Warrant Shares at that time issuable pursuant to the exercise of this Warrant shall
be proportionately increased; and, conversely, if Company shall contract the number of outstanding shares of Common Stock by combining
such shares into a smaller number of shares, then the Exercise Price in effect before such combination shall be proportionately increased
and the number of Warrant Shares at that time issuable pursuant to the exercise or conversion of this Warrant shall be proportionately
decreased. Each adjustment in the number of shares of Warrant Stock issuable shall be to the nearest whole share.


 



    2


     


     


13.
Certificate as to Adjustments. In the case of any adjustment in the Exercise Price or Warrant Shares, Company will promptly give
written notice to Investor in the form of a certificate, certified and confirmed by an officer of the Company, setting forth the adjustment
in reasonable detail.


 


14.
Transfer to Comply with the Securities Act. This Warrant and the Warrant Shares have not been registered under the Securities
Act of 1933, as amended (the “1933 Act”). The Warrant Shares may not be sold, transferred, pledged or hypothecated
without (a) an effective registration statement under the 1933 Act relating to such security or (b) an opinion of counsel reasonably
satisfactory to Company that registration is not required under the 1933 Act. Until such time as registration has occurred under the
1933 Act, each certificate for this Warrant and any Warrant Shares shall contain a legend, in form and substance satisfactory to counsel
for Company, setting forth the restrictions on transfer contained in this Section 7. This Warrant may be transferred by Investor so long
as such transfer is done in compliance with applicable securities laws. Upon receipt of a duly executed assignment of this Warrant, Company
shall register the transferee thereon as the new holder on the books and records of Company and such transferee shall be deemed a “registered
holder” or “registered assign” for all purposes hereunder, and shall have all the rights of Investor under this Warrant.
Until this Warrant is transferred on the books of Company, Company may treat Investor as the absolute owner hereof for all purposes,
notwithstanding any notice to the contrary


 


15.
Notices. Any notice required or permitted hereunder shall be given in the manner provided in the subsection titled “Notices”
in the Purchase Agreement, the terms of which are incorporated herein by reference. Company shall provide Investor with prompt written
notice of all actions taken pursuant to this Warrant, including in reasonable detail a description of such action and the reason therefor.
Without limiting the generality of the foregoing, Company will give written notice to Investor (i) as soon as practicable upon each adjustment
of the Exercise Price and the number of Warrant Shares, setting forth in reasonable detail, and certifying, the calculation of such adjustment(s),
(ii) at least fifteen (15) days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend
or distribution upon the Common Stock, or (B) for determining rights to vote with respect to any Change of Control, dissolution or liquidation,
provided in each case that such information.


 


16.
Supplements and Amendments; Whole Agreement. This Warrant may be amended or supplemented only by an instrument in writing signed
by the parties hereto. This Warrant, together with the Purchase Agreement, contains the full understanding of the parties hereto with
respect to the subject matter hereof and thereof and there are no representations, warranties, agreements or understandings with respect
to the subject matter hereof and thereof other than as expressly contained herein and therein.


 


17.
Governing Law; Venue. This Warrant shall be construed and enforced in accordance with, and all questions concerning the construction,
validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of Delaware, without giving
effect to any choice of law or conflict of law provision or rule that would cause the application of the laws of any jurisdiction other
than the State of Delaware. Any action brought by either party against the other concerning the transactions contemplated by this Agreement
shall be brought only in the state and federal courts in San Diego County, California. The parties to this Agreement hereby irrevocably
waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction
or venue or based upon forum non conveniens. The prevailing party in any dispute arising under this Agreement shall be entitled to recover
from the other party its reasonable attorney’s fees and costs.


 


18.
Waiver of Jury Trial. EACH OF COMPANY AND INVESTOR IRREVOCABLY WAIVES ANY AND ALL RIGHTS IT MAY HAVE TO DEMAND THAT ANY ACTION,
PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR IN ANY WAY RELATED TO THIS WARRANT OR THE RELATIONSHIPS OF THE PARTIES HERETO BE TRIED BY
JURY. THIS WAIVER EXTENDS TO ANY AND ALL RIGHTS TO DEMAND A TRIAL BY JURY ARISING UNDER COMMON LAW OR ANY APPLICABLE STATUTE, LAW, RULE
OR REGULATION. FURTHER, COMPANY ACKNOWLEDGES THAT IT IS KNOWINGLY AND VOLUNTARILY WAIVING ITS RIGHT TO DEMAND TRIAL BY JURY.


 


19.
Counterparts. This Warrant may be executed in any number of counterparts and each of such counterparts shall for all purposes
be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. Electronic signatures
shall be considered original signatures for all purposes hereof.


20.
Attorneys’ Fees. In the event of any litigation or dispute arising from this Warrant, the parties agree that the prevailing
party shall be entitled to an additional award of the full amount of the reasonable attorneys’ fees and expenses paid by said prevailing
party in connection with litigation or dispute.


 


21.
Severability. Whenever possible, each provision of this Warrant shall be interpreted in such a manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be invalid or unenforceable in any jurisdiction, such provision shall
be modified to achieve the objective of the parties to the fullest extent permitted and such invalidity or unenforceability shall not
affect the validity or enforceability of the remainder of this Warrant or the validity or enforceability of this Warrant in any other
jurisdiction.


 


[Remainder
of page intentionally left blank; signature page follows]


 



    3


     


     


IN
WITNESS WHEREOF, Company has caused this Warrant to be duly executed as of the Issue Date.


 


	 	COMPANY:
	 	 	 
	 	HUMBL,
    Inc.
	 	 	 
	 	By:	 
	 	 	Brian
    Foote, CEO


 


[Signature
Page to Warrant]


 



     


     


     


ATTACHMENT
1


DEFINITIONS


 


For
purposes of this Warrant, the following terms shall have the following meanings:


 


A1.
“Closing Trade Price” means the last closing trade price for the Common Stock on its principal market, as reported
by OTC Markets.


 


A2.
“DTC” means the Depository Trust Company or any successor thereto.


 


A3.
“DTC Eligible” means, with respect to the Common Stock, that such Common Stock is eligible to be deposited in certificate
form at the DTC, cleared and converted into electronic shares by the DTC and held in the name of the clearing firm servicing Investor’s
brokerage firm for the benefit of Investor.


 


A4.
“DTC/FAST Program” means the DTC’s Fast Automated Securities Transfer program.


 


A5.
“DWAC” means the DTC’s Deposit/Withdrawal at Custodian system.


 


A6.
“Exercise Price” means $0.017 per share of Common Stock, as the same may be adjusted from time to time pursuant to
the terms and conditions of this Warrant.


 


A7.
“Trading Day” means any day the New York Stock Exchange is open for trading.


 



     


     


     


EXHIBIT
A


 


NOTICE
OF EXERCISE OF WARRANT


 


	TO:	HUMBL,
    INC.
	 	ATTN:
    _______________
	 	EMAIL:
    ______________


 


The
undersigned hereby irrevocably elects to exercise the right, represented by the Warrant to Purchase Shares of Common Stock dated as of
November __, 2022 (the “Warrant”), to purchase shares of the common stock, $0.00001 par value (“Common
Stock”), of HUMBL, Inc., and tenders herewith payment in accordance with Section 2 of the Warrant, as follows:


 


_______
CASH: $__________________________ = (Exercise Price x Warrant Shares)


 


	_______	Payment
    is being made by:
	 	_____
    	enclosed
    check 
	 	_____	wire
    transfer 
	 	_____	other


 


_______
CASHLESS EXERCISE:


 


Net
number of Warrant Shares to be issued to Investor: ______*


 


	 	*
    X =	Y
    (A-B)	 
	 	 	A	 


 


	 	Where	X
    =	the
    number of Warrant Shares to be issued to Investor.
	 	 	 	 
	 	 	Y
    = 	the
    number of Warrant Shares that the Investor elects to purchase under this Warrant (at the date of such calculation).
	 	 	 	 
	 	 	A
    =	the
    Closing Price (on the date two Trading Days prior to the Exercise Date).
	 	 	 	 
	 	 	B
    =	Exercise
    Price (as adjusted to the date of such calculation).


 


Capitalized
terms used but not otherwise defined herein shall have the meanings ascribed to them in the Warrant.


 


It
is the intention of Investor to comply with the provisions of Section 2.2 of the Warrant regarding certain limits on Investor’s
right to receive shares thereunder. Investor believes this exercise complies with the provisions of such Section 2.2. Nonetheless, to
the extent that, pursuant to the exercise effected hereby, Investor would receive more shares of Common Stock than permitted under Section
2.2, Company shall not be obligated and shall not issue to Investor such excess shares until such time, if ever, that Investor could
receive such excess shares without violating, and in full compliance with, Section 2.2 of the Warrant.


 


As
contemplated by the Warrant, this Notice of Exercise is being sent by email to the officer indicated above.


 


If
this Notice of Exercise represents the full exercise of the entire Warrant, Investor will surrender (or cause to be surrendered) the
Warrant to Company at the address indicated above by express courier within five (5) Trading Days after the Warrant Shares to be delivered
pursuant to this Notice of Exercise have been delivered to Investor.


 


To
the extent the Warrant Shares are not able to be delivered to Investor via the DWAC system, please deliver certificates representing
the Warrant Shares to Investor via reputable overnight courier after receipt of this Notice of Exercise (by facsimile transmission or
otherwise) to:


 


	 		 
	 		 
	 		 


 


	Dated:	 	 


 


	 	 
	[Name
    of Investor]	 


 


	By: